Press Releases

TxCell SA (FR0010127662 – TXCL), a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that the European Commission (EC) has granted orphan drug...

Angers, France, December 16, 2014 - CARLINA Technologies, a biotechnology company specializing in the development of nanomedicines, today announces the signing of a partnership agreement with Atlangram for the development of innovative pharmaceutical forms of antibiotics for the targeting...

Germany-based Evotec is negotiating with French drugmaker Sanofi for a multi-component strategic collaboration over the next five years. The alliance will include three major strategic initiatives, focusing on improving innovation effectiveness in drug...

Mylan Laboratories has signed an agreement with Gilead Sciences to increase access to Tenofovir Alafenamide (TAF) based HIV treatments in developing countries. Mylan received non-exclusive rights to manufacture and distribute TAF as both...

Japan-based Daiichi Sankyo has signed an agreement with UCB Biopharma to jointly commercialise Lacosamide for the treatment of patients with epilepsy in Japan. As part of the deal, UCB will manufacture and supply...

British drug-maker GlaxoSmithKline (GSK) has submitted a marketing authorisation application to the European Medicines Agency (EMA) seeking an additional indication for eltrombopag (Revolade). The application was filed for additional indication of the drug to treat adult...

Cologne, Germany, November 12, 2014 / B3C newswire / -New Oncology announced today that it has entered into a collaboration with the National Cancer Centre Singapore (NCCS). Under this agreement, New Oncology will apply its proprietary diagnostic platform ‘NEO’...